Literature DB >> 18688812

Detection of JC virus DNA fragments but not proteins in normal brain tissue.

Georgina Perez-Liz1, Luis Del Valle, Antonio Gentilella, Sidney Croul, Kamel Khalili.   

Abstract

OBJECTIVE: Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the white matter affecting immunocompromised patients that results from the cytolytic destruction of glial cells by the human neurotropic JC virus (JCV). According to one model, during the course of immunosuppression, JCV departs from its latent state in the kidney and after entering the brain, productively infects and destroys oligodendrocytes. The goal of this study was to test the hypothesis that JCV may reside in a latent state in a specific region of the brains of immunocompetent (non-PML) individuals without any neurological conditions.
METHODS: Gene amplification was performed together with immunohistochemistry to examine the presence of JCV DNA sequences and expression of its genome in five distinct regions of the brain from seven immunocompetent non-PML individuals.
RESULTS: Although no viral proteins were expressed in any of these cases, fragments of the viral DNA were present in various regions of normal brain. Laser-capture microdissection showed the presence of JCV DNA in oligodendrocytes and astrocytes, but not in neurons.
INTERPRETATION: The detection of fragments of viral DNA in non-PML brain suggests that JCV has full access to all regions of the brain in immunocompetent individuals. Thus, should the immune system become impaired, the passing and/or the resident virus may gain the opportunity to express its genome and initiate its lytic cycle in oligodendrocytes. The brain as a site of JCV latency is a possibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688812      PMCID: PMC2632778          DOI: 10.1002/ana.21443

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  33 in total

Review 1.  Progressive multifocal leukoencephalopathy.

Authors:  J R Berger; E O Major
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

2.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

3.  Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy.

Authors:  L Del Valle; S Croul; S Morgello; S Amini; J Rappaport; K Khalili
Journal:  J Neurovirol       Date:  2000-06       Impact factor: 2.643

4.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

Review 5.  Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions.

Authors:  Joseph R Berger
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

6.  Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma.

Authors:  Luis Del Valle; Jennifer Gordon; Sahnila Enam; Serena Delbue; Sidney Croul; Selvajothi Abraham; Sujatha Radhakrishnan; Martha Assimakopoulou; Christos D Katsetos; Kamel Khalili
Journal:  J Natl Cancer Inst       Date:  2002-02-20       Impact factor: 13.506

7.  Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual.

Authors:  R A Du Pasquier; S Corey; D H Margolin; K Williams; L-A Pfister; U De Girolami; J J Mac Key; C Wüthrich; J T Joseph; I J Koralnik
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

8.  Role of JC virus agnoprotein in DNA repair.

Authors:  Armine Darbinyan; Khwaja M Siddiqui; Dorota Slonina; Nune Darbinian; Shohreh Amini; Martyn K White; Kamel Khalili
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 9.  Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis.

Authors:  Martyn K White; Kamel Khalili
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

10.  Analysis of the excreted JC virus strains and their potential oral transmission.

Authors:  Sílvia Bofill-Mas; Pilar Clemente-Casares; Eugene O Major; Blanche Curfman; Rosina Girones
Journal:  J Neurovirol       Date:  2003-08       Impact factor: 2.643

View more
  52 in total

1.  JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.

Authors:  Tom Van Loy; Kim Thys; Caroline Ryschkewitsch; Ole Lagatie; Maria C Monaco; Eugene O Major; Luc Tritsmans; Lieven J Stuyver
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

Review 2.  Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.

Authors:  A Bellizzi; C Nardis; E Anzivino; D M Rodìo; D Fioriti; M Mischitelli; F Chiarini; V Pietropaolo
Journal:  J Neurovirol       Date:  2012-02       Impact factor: 2.643

Review 3.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

4.  JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Authors:  Spyridon Chalkias; Xin Dang; Evelyn Bord; Marion C Stein; R Philip Kinkel; Jacob A Sloane; Maureen Donnelly; Carolina Ionete; Maria K Houtchens; Guy J Buckle; Stephanie Batson; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-10       Impact factor: 10.422

5.  Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.

Authors:  Hassen S Wollebo; Mahmut Safak; Luis Del Valle; Kamel Khalili; Martyn K White
Journal:  J Neuroimmunol       Date:  2010-12-24       Impact factor: 3.478

6.  Detection of human polyomavirus proteins, T-antigen and agnoprotein, in human tumor tissue arrays.

Authors:  Luis Del Valle; Kamel Khalili
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

7.  Lymphotropic polyomavirus and progressive multifocal leukoencephalopathy.

Authors:  Daniele Focosi; Richard Eric Kast; Fabrizio Maggi; Luca Ceccherini-Nelli; Mario Petrini
Journal:  J Clin Microbiol       Date:  2009-01       Impact factor: 5.948

Review 8.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

Review 9.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

10.  The 50th birthday of progressive multifocal leukoencephalopathy: New insights into pathogenesis.

Authors:  Kenneth L Tyler
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.